Oxycodone is a prescription pain medication used to treat moderate to severe pain, with addictive properties and physiological side effects.1 This opioid belongs to the group of pain medicines called Narcotic Analgesics. It directly impacts the Central Nervous System (CNS) to relieve pain.
Oxycodone comes in two forms: Immediate-release or Extended-Release. The extended-release tablet slowly delivers the medication throughout the body throughout the day, whereas the immediate-release tablet begins relieving pain within 15 to 30 minutes after consumption.
Although oxycodone is the generic name, familiarizing oneself with the several branded names would help prevent overusing the same medication that would lead to an overdose.2
Percocet is a combination of oxycodone and acetaminophen. This pharmaceutical is an opioid. Oxycodone Acetaminophen or Percocet are usually prescribed post-surgery to relieve pain and to enhance recovery. For example, Percocet is a common pharmaceutical medication for post-cesarian births.3
Some of the possible side effects include:
OxyNeo is the new oxycodone hydrochloride controlled-release tablets formulated to reduce misuse. The idea behind the OxyNeo tablet is the delayed process of consumption due to its chemical properties.4 When the OxyNeo tablet is mixed with water, it becomes a thick, gel-like substance, which is difficult to inject.4
Despite the hopes of the new Oxycodone formula, the OxyNeo, reducing substance misuse – Health Canada continues to warn that OxyNeo is not exempt from misusage and can still result in an overdose. An overdose can occur either through ingesting the tablet or administering the prescription in doses higher than the recommended amount.
The difference is in the Oxycodone dosage. The Controlled-release formula, also known as Oxycodone-CR, contains more Oxycodone dosage (5 mg to 80 mg) than the immediate-release formula Oxycodone-IR (5 mg to 20 mg). This difference minimizes the dosing frequency. 4 When the controlled-release tablet is swallowed whole, some oxycodone is released immediately; the rest is released into the body slowly due to a protective coating. However, if the tablet is chewed, crushed, or dissolved, the medication is released all at once. This chewing may happen accidentally or deliberately to achieve a high.
Hydrocodone and Oxycodone are both classified as opioids prescribed to treat symptoms of moderate-to-severe pain. Both medications are available in extended-release forms for ongoing treatment over a week.
The differences between Hydrocodone vs. Oxycodone are that they vary slightly in side effects. Due to the addictive properties of both medications – neither Hydrocodone nor Oxycodone are fitting for everyone. Anyone with a history of substance use disorder should avoid taking them.
Opioid analgesics work by impacting pain processing within the brain and central nervous system. Hydrocodone and Oxycodone are both labeled Schedule II drugs, equivalent to a high potential for abuse.
The concept of addiction often carries several misconceptions, either due to misleading information or the lack of familiarity with the cycle of addiction. Understand the cycle of addiction is one of the most important ways of preventing its continuation.
Although this medication requires a prescription from a licensed doctor, prescribed medication can quickly start an addiction cycle. This cycle can begin from left-over prescribed substances, accessing prescribed substances from others, or becoming dependent on the prescribed substance. This cycle does not favor any age group and can affect people as younger than teenagers.
The most common prescription drugs abused include:5
According to John Hopkins Medicine, Substance dependence is the medical term used to describe the abuse of drugs or alcohol that continues even when significant problems related to their use have developed.6
Signs of dependence include:
According to the National Institute on Drug Abuse, “[a]ddiction is a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.”
The problem with addiction stems from the initial purpose of consuming a substance once
“but repeated drug use can lead to brain changes that challenge self-control and interfere with the ability to resist intense urges to take drugs. These brain changes can be persistent, which is why drug addiction is considered a “relapsing” disease—people in recovery from drug use disorders are at increased risk for returning to drug use even after years of not taking the drug.”7
Opioids are powerful pain-relieving medications. Oxycodone is a good recovery option for someone in short-term pain. However, this does not take away from the fact that opioids, like Oxycodone, are highly associated with substance abuse at high rates, addiction, and overdose. There are ways to identify when an addiction to Oxycodone is taking place.
According to the American Academy of Family Physicians, the following are signs of addiction:
According to the National Institute on Drug Abuse,
“[a]n opioid overdose occurs when a person uses enough of the drug to produce life-threatening symptoms or death. When people overdose on opioid medication, their breathing often slows or stops. The slowed breathing can decrease the amount of oxygen that reaches the brain, which can result in coma, permanent brain damage, or death.”
As with any medication, the wanted effects should occur – yet unwanted side effects may also occur. Oxycodone side effects vary between short- and long-term effects.8
Hypoxia is a long-term Oxycodone side effect.8 This being a condition in which little oxygen reaches the brain, resulting in psychological and neurological effects. These effects include coma, permanent brain damage, or even death.
Oxycodone withdrawal symptoms can begin as early as a few hours after the last dosage.8
The symptoms are uncomfortable in many cases of opioid use disorders. The symptoms include:
Oxycodone treatments include both medicine and behavioral therapy to help address the substance use disorder.
Detox centers are an effective way to detox from prescription medicine. With trained medical and clinical professionals, detox centers are a safe and supportive way to evaluate and address your needs.
Medication-assisted treatments target the brain’s receptors. According to the National Institute on Drug Abuse,
“Two medicines, buprenorphine, and methadone, work by binding to the same opioid receptors in the brain as the opioid medicines, reducing cravings and withdrawal symptoms. Another medicine, naltrexone, blocks opioid receptors and prevents opioid drugs from having an effect.”8
Inpatient rehab includes behavioral therapy that focuses on changing how individuals with a substance use disorder behave and perceive their relationship to the substances. 10 Some examples include cognitive behavioral therapy, which helps modify drug use expectations and behaviors while also effectively managing triggers and stress.9
Gregory Ng is the CEO of Brooks Bell. In his nearly 25 years in marketing, Greg has created innovative solutions leading to digital and cognitive transformations for the biggest high-tech, retail and financial brands in the world. Greg adds knowledge in marketing strategy, content production, and brand awareness to the AHV advisory board.
Hunt Broyhill holds several positions within the Broyhill family offices and serves as President, Chairman, and Chief Executive Officer of BMC Fund and Chief Executive Officer of Broyhill Asset Management. Hunt brings valuable experience in capital allocation, real estate, and investor relations to the AHV advisory board.
Alan Hughes was formerly the Executive Vice President and Chief Operating Officer at Blue Cross and Blue Shield of North Carolina. In addition to BCBS, Alan held officer positions in both operations and technology at GE Commercial Finance, Deutsche Bank, and American Express. Alan brings a unique combination of efficient process design and technological problem solving to the AHV advisory board.
Lynn is the CEO of Broadstep. Previously, Lynn held various roles in both healthcare and finance where she oversaw multi-site, multi-state organizations within primary care, acute and chronic services, hospitals, and pharmacies. Lynn brings valuable experience in healthcare leadership, recruiting, and growth strategy to the AHV advisory board.
John Roos is the retired Senior Vice President and Chief Growth Officer for Blue Cross and Blue Shield of North Carolina. Under Roos’s tenure, the company’s revenue grew from $1.5 billion to $9.5 billion, while adding 1 million members. John brings valuable experience in growth strategy, enterprise sales, and provider contracting to the AHV advisory board.
Dr. Hendree Jones is the Executive Director of UNC-Horizons and an internationally recognized expert in behavioral and pharmacologic treatments for pregnant women and their children. Dr. Jones has received continuous funding from the National Institutes of Health since 1994 and has over 200 peer-reviewed publications. Dr. Jones is an advisor to the UN, WHO, SAMHSA, ASAM, and ACOG through which she consults throughout the United States and internationally. Dr. Jones brings valuable experience in grant writing, research, and healthcare administration to the AHV advisory board.
Brad is the CEO Emeritus for BCBSNC and Chair of the BCBSNC Foundation. He served as Gov. Jim Hunt’s general counsel and is a past chair of the UNC Board of Governors. Brad serves on numerous public and private boards and is a lifelong North Carolinian with degrees from Appalachian State, Wake Forest, and Duke. He brings valuable experience in healthcare, law, higher education, and politics.
Jake Summers is a passionate entrepreneur who is dedicated to bringing the energy of change to existing healthcare business models and making higher quality healthcare more accessible. Jake co-founded a mango farming/export company in Cambodia and serves as an advisor for a number of small businesses. Jake is the co-founder of Advaita Integrated Medicine and is the Development Director and a Partner of Green Hill.
Tripp Johnson is a serial healthcare entrepreneur who’s dedicated his post-military professional life to serving young adults. He is the co-founder of Advaita Integrated Medicine, Advaita Health Ventures, and Green Hill Recovery. Tripp is passionate about making quality healthcare more affordable and accessible through innovative business models and technology-focused solutions.